Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989
Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in ratsJ P Case, H Lorberboum-Galski, R Lafyatis, et al.The Journal of Biological Chemistry|December 15, 1988
Interleukin 2 (IL2) PE40 is cytotoxic to cells displaying either the p55 or p70 subunit of the IL2 receptorH Lorberboum-Galski, R W Kozak, T A Waldmann, et al.European Journal of Biochemistry|March 3, 1986
Small cytoplasmic RNAs from human placental free mRNPs. Structure and their effect on in vitro protein synthesisH Lorberboum, M Digweed, V A Erdmann, et al.Journal of Neuroimmunology|June 1, 1991
Chimeric cytotoxin IL2-PE40 inhibits relapsing experimental allergic encephalomyelitisJ W Rose, H Lorberboum-Galski, D Fitzgerald, et al.Molecular Biology Reports|March 31, 1982
RNA synthesis in cultured human placentaH Lorberboum, D Weinstein, H Galski, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1989
Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40. Inhibition of experimental autoimmune uveoretinitisF G Roberge, H Lorberboum-Galski, P Le Hoang, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1989
Cardiac allograft survival in mice treated with IL-2-PE40H Lorberboum-Galski, L V Barrett, R L Kirkman, et al.Molecular and Cellular Endocrinology|April 1, 1982
The synthesis and secretion of human placental lactogen (hPL) in cultured term placentaD Weinstein, H Galski, J G Schenker, et al.Transplantation|September 1, 1991
Treatment of corneal allograft rejection with the cytotoxin IL-2-PE40C P Herbort, M D de Smet, F G Roberge, et al.The Journal of Biological Chemistry|September 25, 1990
IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytesH Lorberboum-Galski, R J Garsia, M Gately, et al.Pageof 5